PÃ¶ss J, Ukena C, Kindermann I, Ehrlich P, Fuernau G, Ewen S, et al
. Angiopoietin-2 and outcome in patients with acute decompensated heart failure. Clin Res Cardiol. 2015;104:380-7 pubmed publisher
..8; 95 % confidence interval; 2.48-31.16, p < 0.001). In ADHF patients, Ang-2 is significantly increased compared to healthy controls, shows a relationship in the presence of oedema and is a predictor of poor outcome. ..
PÃ¶ss J, Kriechbaum S, Ewen S, Graf J, HÃ¤ger I, Hennersdorf M, et al
. First-in-man analysis of the i-cor assist device in patients with cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2015;4:475-81 pubmed publisher
..This first-in-man analysis suggests that the i-cor ECMO device is successfully applicable in humans. The data set the stage for further evaluation of this novel system and provide the necessary basis to design randomised evaluations. ..
PÃ¶ss J, Ewen S, Schmieder R, Muhler S, Vonend O, Ott C, et al
. Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension. Clin Res Cardiol. 2015;104:672-8 pubmed publisher
..RDN lowered BP and increased estimated UNa and fractional sodium excretion in patients with resistant hypertension independently of renal function and antihypertensive therapy. ..
Eitel I, PÃ¶ss J, Jobs A, Eitel C, de Waha S, Barkhausen J, et al
. Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2015;17:62 pubmed publisher
..ClinicalTrials.gov: NCT00712101. ..
Pöss J, Köster J, Fuernau G, Eitel I, de Waha S, Ouarrak T, et al
. Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 2017;69:1913-1920 pubmed publisher
..It may help stratify patient risk for short-term mortality and might, thus, facilitate clinical decision making. (Intraaortic Balloon Pump in Cardiogenic Shock II [IABP-SHOCK II]; NCT00491036). ..